Search - tctmd.com

Displaying 301 - 320 of 359

Sort: Relevancy | Date

News Daily News

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

Yael L. Maxwell

June 11, 2014

News Industry News

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

May 07, 2014

News Conference News ACC 2014

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Yael L. Maxwell

March 30, 2014

News Daily News

Registry Data Support Efficacy of Revascularization in Stable Patients

March 27, 2014

News Daily News

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

L.A. McKeown

March 20, 2014

News Daily News

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Caitlin E. Cox

March 20, 2014

Presentation

Effects of ACE Inhibitors and Beta-Blockers on Clinical Outcomes in Patients With and Without Coronary Artery Obstructions at Angiography

Presenter: O. Manfrini

March 14, 2014

News Daily News

PCI Patients More Likely to Die from Noncardiac Causes

L.A. McKeown

February 12, 2014

News Daily News

Sweden Better than United Kingdom at Saving Lives of MI Patients

L.A. McKeown

January 29, 2014

News Daily News

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Yael L. Maxwell

December 08, 2013

News Conference News AHA 2013

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Yael L. Maxwell

November 16, 2013

News Daily News

Findings Support DAPT Duration Longer Than 3 Months in ACS Patients

L.A. McKeown

November 01, 2013

News Daily News

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

L.A. McKeown

September 27, 2013

News Daily News

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

September 20, 2013

News Conference News ESC 2013

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Caitlin E. Cox

September 04, 2013

News Daily News

Late-Onset A-fib After MI Signals More Hospitalizations, Emergency Visits

August 30, 2013

News Daily News

Study Looks at Differences in PCI Outcomes at Teaching vs. Non-Teaching Hospitals

Yael L. Maxwell

August 12, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

News Daily News

Novel Urinary Inflammation Marker Sharpens Prognosis of Stable CAD

August 05, 2013

News Daily News

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

L.A. McKeown

July 24, 2013

Advertisement

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Registry Data Support Efficacy of Revascularization in Stable Patients

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Effects of ACE Inhibitors and Beta-Blockers on Clinical Outcomes in Patients With and Without Coronary Artery Obstructions at Angiography

PCI Patients More Likely to Die from Noncardiac Causes

Sweden Better than United Kingdom at Saving Lives of MI Patients

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Findings Support DAPT Duration Longer Than 3 Months in ACS Patients

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Late-Onset A-fib After MI Signals More Hospitalizations, Emergency Visits

Study Looks at Differences in PCI Outcomes at Teaching vs. Non-Teaching Hospitals

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

Novel Urinary Inflammation Marker Sharpens Prognosis of Stable CAD

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content